Biometric Analysis of Melanoma Cells Due to Various Metastasis Origin
- Authors: Palkina N.V.1, Komina A.V.1, Aksenenko M.B.1, Ruksha T.G.1
-
Affiliations:
- Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
- Issue: Vol 93, No 6 (2017)
- Pages: 60-66
- Section: ORIGINAL STUDIES
- Submitted: 02.02.2018
- Accepted: 02.02.2018
- Published: 29.12.2017
- URL: https://vestnikdv.ru/jour/article/view/354
- DOI: https://doi.org/10.25208/0042-4609-2017-93-6-60-66
- ID: 354
Cite item
Full Text
Abstract
About the authors
N. V. Palkina
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
Author for correspondence.
Email: MosmanNV@yandex.ru
PhD (Medicine), Research Assistant, Department of Pathophysiology named after Prof. V. V. Ivanov
РоссияA. V. Komina
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
Email: fake@neicon.ru
PhD (biology), Researcher, Department of Pathophysiology named after Prof. V. V. Ivanov
РоссияM. B. Aksenenko
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
Email: fake@neicon.ru
PhD (Medicine), Associate Professor, Department of Pathophysiology named after Prof. V. V. Ivanov
РоссияT. G. Ruksha
Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky, Ministry of Health of the Russian Federation
Email: fake@neicon.ru
D.Sci. (Medicine), Head of the Department of Pathophysiology named after Prof. V. V. Ivanov
РоссияReferences
- Каприн А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). М.: МНИОИ им. П. А. Герцена, 2017. [Kaprin A. D., Starinskiy V. V., Petrova G. V. Malignancies in Russia in 2015 (Morbidity and Mortality). M.: MNIOI im. P. A. Gertsena, 2017.]
- Ferris L. K., Harris R. J. New Diagnostic Aides for Melanoma. Dermatol. Clin. 2012;30(3):535–545.
- Ferrara G., De Vanna A. C. Fluorescence in situ Hybridization for Melanoma Diagnosis: A Review and a Reappraisal. Am. J. Dermatopathol. 2016;38(4):253–269.
- Sun X., Yu Q. Intra-Tumor Heterogeneity of Cancer Cells and its Implications for Cancer Treatment. Acta Pharmacol. Sin. 2015;36(10):1219– 1227.
- Tellez-Gabriel M., Ory B., Lamoureux F. et al. Tumour Heterogeneity: the Key Advantages of Single-Cell Analysis. Int. J. Mol. Sci. 2016;17(12):2142.
- Oettgen H. F., Aoki T., Old L. J. et al. Suspension Culture of a Pigment-Producing Cell Line Derived from a Human Malignant Melanoma. J. Natl. Cancer Inst. 1968;41(4):827–843.
- Mohr P., Eggermont A. M. M., Hauschild A. et al. Staging of Cutaneous Melanoma. Ann. Oncol. 2009;20(6):vi14–vi21.
- Lockshin A., Giovanella B. C., De Ipolyi P. D. et al. Exceptional Lethality for Nude Mice of Cells Derived from a Primary Human Melanoma. Cancer Res. 1985;45(1):345–350.
- Turajlic S., Furney S. J., Lambros M. B. et al. Whole Genome Sequencing of Matched Primary and Metastatic Acral Melanomas. Genome Res. 2012;22(2):196–207.
- Vogelstein B., Papadopoulos N., Velculescu V. E. et al. Cancer Genome Landscapes. Science. 2013;339(6127):1546–1558.
- Guan X. Cancer Metastases: Challenges and Opportunities. Acta Pharm. Sin. B. 2015;5(5):402–418.
- Zhou F., Wang W., Shen C. et al. Epigenome-Wide Association Analysis Identified Nine Skin DNA Methylation Loci for Psoriasis. J. Invest. Dermatol. 2016;136(4):779–787.
- Bin L., Leung D. Y. M. Genetic and Epigenetic Studies of Atopic Dermatitis. Allergy Asthma Clin. Immunol. 2016;12:52.
- Chew E. G. Y., Ho B. S. Y., Ramasamy S. et al. Comparative Transcriptome Profiling Provides New Insights into Mechanisms of Androgenetic Alopecia Progression. Br. J. Dermatol. 2016;176(1):265–269.
- Heywood W. E., Benatti M., Sebire N. J. et al. An Optimised Method for the Proteomic Profiling of Full Thickness Human Skin. Biol. Proced. Online. 2016;18:15.